Spiro Konstantinov
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Oncology top 10%
- Biomaterials top 5%
- Materials Chemistry
- Co-authors
- Martin R. BergerHansjörg EiblMartin BergerMargarita KaraivanovaGeorgi MomekovMargarita Topashka-AnchevaKrassimira YonchevaIlia Manolov
- Topics
- Metal complexes synthesis and properties (18 papers)Nanoparticle-Based Drug Delivery (14 papers)Curcumin's Biomedical Applications (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEInternational Journal of Molecular Sciences
In The Last Decade
Spiro Konstantinov
107 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 782
- Organic Chemistry 616
- Oncology 383
- Biomaterials 288
- Materials Chemistry 219
Countries citing papers authored by Spiro Konstantinov
This map shows the geographic impact of Spiro Konstantinov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spiro Konstantinov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spiro Konstantinov more than expected).
Fields of papers citing papers by Spiro Konstantinov
This network shows the impact of papers produced by Spiro Konstantinov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spiro Konstantinov. The network helps show where Spiro Konstantinov may publish in the future.
Co-authorship network of co-authors of Spiro Konstantinov
This figure shows the co-authorship network connecting the top 25 collaborators of Spiro Konstantinov. A scholar is included among the top collaborators of Spiro Konstantinov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spiro Konstantinov. Spiro Konstantinov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 11 | |
| 6 | 5 | |
| 7 | 11 | |
| 8 | 12 | |
| 9 | 11 | |
| 10 | 67 | |
| 11 | 30 | |
| 12 | 14 | |
| 13 | 11 | |
| 14 | 19 | |
| 15 | 17 | |
| 16 | 5 | |
| 17 | 144 | |
| 18 | 40 | |
| 19 | 2 | |
| 20 | Erucylphosphocholine is the prototype of i. v. injectable alkylphosphocholines. | 26 |
About Spiro Konstantinov
Spiro Konstantinov is a scholar working on Molecular Medicine, Biomaterials and Toxicology, having authored 110 papers that have together received 2.0k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (18 papers), Nanoparticle-Based Drug Delivery (14 papers) and Curcumin's Biomedical Applications (9 papers). The work is most often cited by research in Molecular Medicine (168 citations), Biomaterials (288 citations) and Organic Chemistry (616 citations). Spiro Konstantinov has collaborated with scholars based in Bulgaria, Germany and Hungary. Frequent co-authors include Martin R. Berger, Hansjörg Eibl, Martin Berger, Margarita Karaivanova, Georgi Momekov, Margarita Topashka-Ancheva, Krassimira Yoncheva, Ilia Manolov, Irena Kostova and Maya M. Zaharieva. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.